| Generic name | Mercaptopurine |
| Pronunciation | mer-kap-toh-PYOOR-een |
| Brand name(s), other common name(s) | Purinethol®, 6-MP, Purixan® |
| Drug type | Antimetabolite |
| How the drug is given | By mouth; liquid medication |
Indications and Usage
Mercaptopurine is FDA approved to treat people who have acute lymphoblastic leukemia as part of a combination regimen.
Side effects needing medical attention
Fever, chills or sore throat; unusual bleeding or bruising; unusual tiredness or weakness; yellowing of eyes and skin; loss of appetite; side or stomach pain; joint pain; nausea and vomiting; swelling of feet or lower legs; black, tarry stools; sores in mouth or on lips.
Side effects needing medical attention after stopping this medication
Fever, chills or sore throat; unusual bleeding or bruising; yellowing of eyes and skin.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.